TrialEuropean journal of clinical pharmacology2013

Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers.

Yu Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.